---
$id: https://graph.org.ai/products/commodity/51281613
$type: Product
source: UNSPSC
code: "51281613"
title: "Framycetin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Framycetin

**UNSPSC Code**: 51281613
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H46N6O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4BOC774388, chemically known as d-streptamine, o-2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1-4)-o-(o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1-3)-beta-d-ribofuranosyl-(1-5))-2-deoxy- but generally known as framycetin, which bears US NIH Compound Identifier 8378. European Medicines Agency schedules Framycetin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07814MIG. The term FRAMYCETIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules framycetin in its Anatomical Therapeutic Chemical (ATC) Classification. FRAMYCETIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule framycetin under HS 29419000 and SITC 54139. As of Q4 2014, FRAMYCETIN remains the US FDA Preferred Term for this commodity. Framycetin bears US NLM identifiers UMLS ID C0016673 and NCI Concept Code C65770. SMILES: O(C1C(OC2OC(C(O)C(O)C2N)CN)C(N)CC(N)C1O)C1OC(C(OC2OC(C(O)C(O)C2N)CN)C1O)CO.

